6 No source found (not proven false)
In rodents subjected to starvation or severe hunger, dopamine encodes aversive events and punishment prediction errors rather than reward prediction errors.
"in rodents it's very clear, I guess at the level of the amygdala, if you make a rodent hungry then you can show that dopamine will encode something like punishment prediction errors, not reward prediction errors. In other words, it does it's like it flips its role... he puts animals in starvation states and he shows that dopamine will encode aversive events, aversive errors." (said at 1:12:03)
No published studies matching the specific claim—that starvation or severe hunger in rodents causes amygdalar (or other regional) dopamine signaling to flip from encoding reward prediction errors to punishment or aversive prediction errors—were identified in the literature searches conducted. While dopamine in the amygdala and mesolimbic circuits is known to respond to salience and aversive stimuli under specific experimental conditions, the precise mechanism and paradigm described by the speaker could not be verified in indexed records. This lack of retrieval does not prove the claim false, but it remains unverified.
Electrochemical probes inserted into the nasal cavity can measure dopamine and serotonin fluctuations in healthy humans during behavioral tasks.
"You can consent healthy people into doing this. You can snake this thing up there and clip it to their nostril, set up the electronics beside them, and then you can do all kinds of stuff, including letting them eat, letting them do mindfulness meditation, breathing exercises, letting them do decision-making tasks with and without other people." (said at 1:33:42)
A systematic search of PubMed and Europe PMC for electrochemical or voltammetric probe recordings of dopamine and serotonin via the human nasal cavity/olfactory mucosa during behavioral tasks yielded no matching published peer-reviewed studies. While fast-scan cyclic voltammetry has been performed in humans invasively during deep brain stimulation (DBS) neurosurgery in clinical cohorts, no published record documenting an intranasal electrochemical probe measuring dynamic dopamine and serotonin fluctuations in healthy human subjects during tasks was located. This lack of published records does not prove the technique does not exist or is not under active development, but the claim cannot be verified against the existing literature.
Neurotransmitter recordings obtained from the nasal cavity mirror the responses of midbrain neurons during cue, reward, and affective picture presentations.
"What we see in the nasal recordings looks very much like exactly what we would expect if we were recording from the neurons in the midbrain based on what people have recorded on the simple experiments. You know, there's a cue, there's a reward, there's this, it went up, it went down, that kind of thing. There: this is a positive picture, this is a negative picture, this is positive affect, this is negative affect." (said at 1:35:52)
No published peer-reviewed studies were located documenting real-time electrochemical or neurotransmitter recordings from the nasal cavity that mirror midbrain neuronal dynamics during cue, reward, or affective picture presentations. The claim appears to describe unpublished pilot findings or proprietary experimental work.
Nasal probe recordings show that respiration aligns with hydrogen peroxide and dopamine/norepinephrine signals when subjects update models during economic exchange tasks.
"The pattern that we see recording up the nose, uh, is reg—the breathing is registered cleanly with the peroxide signal, which is a which is a proxy for mitochondrial function, and the dopamine signal, and the norepi signal." (said at 1:41:06)
No published peer-reviewed studies were identified documenting nasal probe recordings that measure simultaneous breathing, hydrogen peroxide, and dopamine/norepinephrine electrochemical signals during economic exchange or decision-making tasks. This appears to refer to unpublished laboratory findings or ongoing preliminary work, and the absence of published literature does not prove the claim false.
Administering L-dopa to healthy individuals without Parkinson's disease or schizophrenia at sufficient doses can induce hallucinations and paranoia.
"If you take L-dopa and you don't have Parkinson's and you don't have schizophrenia, I can find a dose where you will start to hear voices. I can find a dose where you will start to feel paranoid. I can make you schizophrenic." (said at 2:07:34)
No published records directly evaluating or confirming the claim that administering L-dopa alone to healthy volunteers without Parkinson's disease or schizophrenia at high doses induces auditory hallucinations, paranoia, or schizophrenia were fetched within the search parameters. While dopamine agonist and precursor therapies are well-documented to induce psychosis and hallucinations in patients with Parkinson's disease, direct experimental evidence demonstrating de novo auditory hallucinations and paranoia from L-dopa titration in healthy individuals was not retrieved. This lack of retrieved publication does not prove the claim false.
Geoffrey Hinton earned his PhD in psychology.
"He's a psychologist, too... His PhD is in psychology... Hinton." (said at 2:25:47)
No retrieved record contains specific biographical details documenting the exact formal discipline of Geoffrey Hinton's doctoral degree.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.